Stellate cells and mesenchymal stem cells in benign mammary stroma are associated with risk factors for breast cancer - an observational study

BMC Cancer
Björn L IsfossHakan Olsson

Abstract

It is not known whether stromal cells in benign breast tissue can mediate risk of breast cancer. We recently described aldehyde dehydrogenase 1 A1 (ALDH1) positive (+) cells in morphologically normal breast stroma of premenopausal women, and the data indicated that their distribution is associated with clinical risk factors for breast cancer. The aim of the present study was to define the identities of these cells using histologic and immunohistologic methods, and to investigate associations between those cells and hormonal and genetic risk factors in pre- and postmenopausal women. Stroma of morphologically normal tissue was analyzed in samples from 101 well-characterized women whose breasts had been operated. Morphology and immunolabeling were applied to determine cell identities based on the putative stem cell markers ALDH1 and stage-specific embryonic antigen-3 (SSEA3), and immunophenotypes indicating mast cells or stellate cells. The results were compared with the patients' risk factors using regression analysis (two-tailed). ALDH1+ round/oval cells were associated with low parity in BRCA1/2 carriers (p = 0.022), while in non-BRCA1/2-carriers they were negatively associated with nulliparity (p = 0.057). In premenopausal wom...Continue Reading

References

Nov 1, 1980·British Journal of Cancer·H O AdamiA J Rimsten
Aug 21, 2003·Lancet·Valerie Beral, UNKNOWN Million Women Study Collaborators
Aug 25, 2005·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Helena JernströmHåkan Olsson
Jan 25, 2007·Breast Cancer Research and Treatment·Joanne KotsopoulosC Bellati
Nov 24, 2007·Nature Reviews. Cancer·James D Fackenthal, Olufunmilayo I Olopade
Jul 10, 2008·Expert Opinion on Drug Metabolism & Toxicology·Satori A MarchittiVasilis Vasiliou
Aug 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Wen-Wei ChangAlice L Yu
Nov 17, 2009·Breast Cancer Research and Treatment·Erika ResetkovaSunil Badve
Jun 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Shohei WakaoMari Dezawa
Nov 5, 2013·Cellular Reprogramming·Yuanyuan YangShaorong Gao
Feb 27, 2014·Virchows Archiv : an International Journal of Pathology·Björn L IsfossAasmund Berner
Jan 7, 2015·Stem Cells Translational Medicine·Kahori KinoshitaKotaro Yoshimura
Dec 2, 2015·Nature Reviews. Clinical Oncology·Catherine C CoombsRoss L Levine
Dec 19, 2015·Proceedings of the National Academy of Sciences of the United States of America·Sarah K C CheungChi-Huey Wong
Mar 30, 2016·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Emiko HoriSatoshi Kuroda
Nov 5, 2016·Breast Cancer Research : BCR·Mikkel MorsingLone Rønnov-Jessen

❮ Previous
Next ❯

Datasets Mentioned

BETA
SAB4503069

Methods Mentioned

BETA
flow cytometry

Software Mentioned

Cell Sense

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.